378. TechMed: Autonomous Surgery Leadership with Nick Damiano of Andromeda Surgical

About this episode

Omar Khateeb interviews Nick Damiano about the future of autonomous surgery and its implications for surgical robotics.

In this episode, Omar Khateeb speaks with Nick Damiano, CEO and Co-Founder of Andromeda Surgical, about how autonomous surgery could redefine surgical robotics.Nick shares how Andromeda is approaching the market differently by focusing on software, autonomy, and real-world surgical data rather than building another traditional robotics platform. The discussion covers their first beachhead in urology, why HoLEP is a powerful starting point, and how better automation could close the gap between novice and expert surgeons.They also explore founder mode in MedTech, why software scales differently than hardware, and how AI-driven robotics could create a new era of surgery for patients, surgeons, and hospitals. This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial…

People in this episode

Host: Omar Khateeb

Guest: Nick Damiano

Topics covered

• autonomous surgery
• surgical robotics
• MedTech
• AI-driven robotics
• urology
• founder journey

Keywords

• autonomous surgery
• surgical robotics
• MedTech
• AI
• urology
• HoLEP
• automation

Mentioned in this episode

Organizations: Andromeda Surgical

More episodes of State of Medtech

• 389.Should You Quit Your Job for a Startup? The Psychology of Startups vs Corporations Through the Barbarians to Bureaucrats Framework · June 10, 2026 · 29 min
• 388.Market Engineering with Bruce Cleveland of Traction Gap Partners · June 8, 2026 · 1h 12m
• 387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics · June 3, 2026 · 1h 22m
• 386.Matt Curl of Apollo.io on Why Modern Go To Market Is Becoming the Biggest Competitive Advantage in Business · June 1, 2026 · 59 min
• 385. How to manage your board using the Elephant Slide · May 27, 2026 · 25 min
• 384: Venture: Virginia Giddings of Edwards Lifesciences & Deborah Kilpatrick of Sonder Capital · May 25, 2026 · 1h 18m